Sensitivity and specificity of eight commercial and one recombinant anti-HIV ELISA tests

Reduced capacity of antibodies from patients infected with human immunodeficiency virus type 1 (HIV-1) group O to neutralize primary isolates of HIV-1 group M viruses.

The Journal of infectious diseases·1995

Resistance of HIV type 1 to proteinase inhibitor Ro 31-8959.

AIDS research and human retroviruses·1995

Renal cell carcinoma extending into the vena cava: surgical approach, technique and results.

British journal of urology·1995

Reactivity of five anti-HIV-1 subtype O specimens with six different anti-HIV screening ELISAs and three immunoblots.

Journal of virological methods·1995

Androgen receptor alterations in patients with disturbances in male sexual development and in prostatic carcinoma.

Urologia internationalis·1995

Protein patterns of benign and malignant human melanocytes show consistent changes in gene expression.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·1995

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Lancet (London, England)·2026

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

Lancet (London, England)·2026

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Lancet (London, England)·2026

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Lancet (London, England)·2026

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Lancet (London, England)·2026

Review Article: Beyond the Therapeutic Ceiling in Inflammatory Bowel Disease-Mechanism-Based Positioning and Emerging Therapeutic Strategies.

Alimentary pharmacology & therapeutics·2026

Cytologic Sub-Categorization of Bethesda Category IV Nodules Has Significant Clinicopathologic Outcomes.

Cytopathology : official journal of the British Society for Clinical Cytology·2026

Efficient detection of human antigen-specific CD4+ T cells with peptide-exchangeable HLA-DP4 tetramers and multiplexed magnetic enrichment.

Journal of immunological methods·2026

Enhancing Tumor Immunogenicity through Hyaluronic Acid-Mediated Delivery of Nonself Antigenic Peptides.

ACS applied bio materials·2026

Outcomes of early amniotic membrane transplantation in acute ocular thermochemical injuries caused by carbide guns in India.

Indian journal of ophthalmology·2026

Diagnostic challenges posed by the wide morphological and immunophenotypic spectrum of plasma cell neoplasms.

Blood research·2026

Related Experiment Videos

Sensitivity and specificity of eight commercial and one recombinant anti-HIV ELISA tests

Related Concept Videos

Reduced capacity of antibodies from patients infected with human immunodeficiency virus type 1 (HIV-1) group O to neutralize primary isolates of HIV-1 group M viruses.

Resistance of HIV type 1 to proteinase inhibitor Ro 31-8959.

Renal cell carcinoma extending into the vena cava: surgical approach, technique and results.

Reactivity of five anti-HIV-1 subtype O specimens with six different anti-HIV screening ELISAs and three immunoblots.

Androgen receptor alterations in patients with disturbances in male sexual development and in prostatic carcinoma.

Protein patterns of benign and malignant human melanocytes show consistent changes in gene expression.

8 weeks versus 12 weeks of sofosbuvir-velpatasvir for treatment-naive, non-cirrhotic, chronic hepatitis C (RESOLVE): a multicentre, open-label, non-inferiority, randomised controlled trial in India.

Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial.

A trembling detour to the diagnosis of encephalitis: a neuroborreliosis case report.

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Efficacy and safety of garetosmab, an activin A-blocking antibody, in fibrodysplasia ossificans progressiva (OPTIMA): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radiotherapy versus observation following surgical resection of WHO grade 2 atypical meningioma (ROAM/EORTC-1308): an international, multicentre, open-label, phase 3, randomised controlled trial.

Review Article: Beyond the Therapeutic Ceiling in Inflammatory Bowel Disease-Mechanism-Based Positioning and Emerging Therapeutic Strategies.

Cytologic Sub-Categorization of Bethesda Category IV Nodules Has Significant Clinicopathologic Outcomes.

Efficient detection of human antigen-specific CD4+ T cells with peptide-exchangeable HLA-DP4 tetramers and multiplexed magnetic enrichment.

Enhancing Tumor Immunogenicity through Hyaluronic Acid-Mediated Delivery of Nonself Antigenic Peptides.

Outcomes of early amniotic membrane transplantation in acute ocular thermochemical injuries caused by carbide guns in India.

Diagnostic challenges posed by the wide morphological and immunophenotypic spectrum of plasma cell neoplasms.

Related Experiment Videos

Sensitivity and specificity of eight commercial and one recombinant anti-HIV ELISA tests

Related Concept Videos

Related Articles